• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:一名长期低密度脂蛋白胆固醇(LDL-C)极低且未接受降脂治疗患者的冠状动脉粥样硬化。

Case report: Coronary atherosclerosis in a patient with long-standing very low LDL-C without lipid-lowering therapy.

作者信息

Mottola Giorgio, Welty Francine K, Mojibian Hamid R, Faridi Kamil F

机构信息

Department of Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States.

Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.

出版信息

Front Cardiovasc Med. 2023 Sep 19;10:1272944. doi: 10.3389/fcvm.2023.1272944. eCollection 2023.

DOI:10.3389/fcvm.2023.1272944
PMID:37795488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10546007/
Abstract

BACKGROUND

ApoB-containing lipoproteins including low-density lipoprotein cholesterol (LDL-C) are necessary for the development of atherosclerosis, and lifelong exposure to low serum levels of LDL-C have been associated with a substantial reduction of cardiovascular risk. Although plaque regression has been observed in patients with serum LDL-C less than 70-80 mg/dl on lipid-lowering therapy, an LDL-C level under which atherosclerosis cannot develop has not been established.

CASE PRESENTATION

In this case we describe a 60-year-old man with well-controlled diabetes mellitus and hypertension who presented to the hospital after an acute stroke likely due to an atrial myxoma discovered on imaging. A coronary computed tomography angiography scan performed in preparation for the planned surgical myxoma resection revealed an anomalous origin of the right coronary artery as well as evidence of nonobstructive coronary atherosclerosis in the right coronary and non-anomalous left coronary system. Despite not having ever been on any lipid-lowering therapy, this patient was found to have low LDL-C levels (<40 mg/dl) during this admission and on routine laboratory data collected over the prior 16 years. His family history strongly suggested heterozygous familial hypobetalipoproteinemia as a possible diagnosis.

CONCLUSIONS

This case illustrates that even long-standing, very low levels of LDL-C may be insufficient to completely prevent atherosclerosis and emphasizes the importance of primordial prevention of all cardiovascular risk factors.

摘要

背景

包括低密度脂蛋白胆固醇(LDL-C)在内的载脂蛋白B的脂蛋白对于动脉粥样硬化的发展是必要的,并且终生暴露于低血清水平的LDL-C与心血管风险的显著降低相关。尽管在接受降脂治疗的血清LDL-C低于70-80mg/dl的患者中观察到斑块消退,但尚未确定一个LDL-C水平,低于该水平动脉粥样硬化就不会发生。

病例报告

在本病例中,我们描述了一名60岁男性,患有控制良好的糖尿病和高血压,因影像学检查发现心房黏液瘤后发生急性中风而入院。为计划中的黏液瘤手术切除进行的冠状动脉计算机断层扫描血管造影显示右冠状动脉起源异常,以及右冠状动脉和非异常左冠状动脉系统存在非阻塞性冠状动脉粥样硬化的证据。尽管该患者从未接受过任何降脂治疗,但在此次入院期间以及在过去16年收集的常规实验室数据中发现其LDL-C水平较低(<40mg/dl)。他的家族史强烈提示可能诊断为杂合子家族性低β脂蛋白血症。

结论

本病例表明,即使长期处于非常低水平的LDL-C也可能不足以完全预防动脉粥样硬化,并强调了对所有心血管危险因素进行一级预防的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b68/10546007/5d5e2d9a772d/fcvm-10-1272944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b68/10546007/5d5e2d9a772d/fcvm-10-1272944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b68/10546007/5d5e2d9a772d/fcvm-10-1272944-g001.jpg

相似文献

1
Case report: Coronary atherosclerosis in a patient with long-standing very low LDL-C without lipid-lowering therapy.病例报告:一名长期低密度脂蛋白胆固醇(LDL-C)极低且未接受降脂治疗患者的冠状动脉粥样硬化。
Front Cardiovasc Med. 2023 Sep 19;10:1272944. doi: 10.3389/fcvm.2023.1272944. eCollection 2023.
2
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.降低“极高”ASCVD 风险患者的靶向致动脉粥样硬化脂蛋白胆固醇目标。
Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y.
3
Low-density lipoprotein apheresis: an evidence-based analysis.低密度脂蛋白单采术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2007;7(5):1-101. Epub 2006 Nov 1.
4
Serum Lipoproteins Are Associated With Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors.血清脂蛋白与无传统危险因素的无症状美国成年人的冠状动脉粥样硬化相关。
JACC Adv. 2024 Jun 13;3(7):101049. doi: 10.1016/j.jacadv.2024.101049. eCollection 2024 Jul.
5
2017 Taiwan lipid guidelines for high risk patients.2017年台湾高危患者血脂指南。
J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24.
6
Does Lowering Low-Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle-Aged Adults? Analysis of the Observational MESA Study.他汀类药物降低低密度脂蛋白胆固醇能否使中年成年人恢复低风险?观察性 MESA 研究分析。
J Am Heart Assoc. 2021 Jun;10(11):e019695. doi: 10.1161/JAHA.120.019695. Epub 2021 May 17.
7
8
HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.HMG-CoA 还原酶抑制剂(他汀类药物)治疗与日本人群的冠状动脉粥样硬化:高密度脂蛋白胆固醇的作用。
Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.
9
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.载脂蛋白脂蛋白脂酶基因 Triglyceride-Lowering LPL 变异体与 LDL 受体基因 LDL-C-Lowering LDLR 变异体与冠心病风险的相关性研究。
JAMA. 2019 Jan 29;321(4):364-373. doi: 10.1001/jama.2018.20045.
10
Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study.强化 LDL 胆固醇降低对冠状动脉粥样硬化进展的影响:一项连续 CT 血管造影研究。
JACC Cardiovasc Imaging. 2017 Apr;10(4):437-446. doi: 10.1016/j.jcmg.2016.04.013. Epub 2016 Oct 19.

本文引用的文献

1
New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing.靶向 PCSK9 的新方法:小干扰核糖核酸和基因组编辑。
Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1081-1092. doi: 10.1161/ATVBAHA.122.317963. Epub 2023 Jun 1.
2
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting in Nonhuman Primate and Mouse Models.在非人类灵长类动物和小鼠模型中靶向 的一种新型单疗程 CRISPR 碱基编辑疗法的疗效和安全性。
Circulation. 2023 Jan 17;147(3):242-253. doi: 10.1161/CIRCULATIONAHA.122.062132. Epub 2022 Oct 31.
3
How to live to 100 before developing clinical coronary artery disease: a suggestion.
如何在患临床冠状动脉疾病之前活到100岁:一项建议。
Eur Heart J. 2022 Jan 31;43(4):249-250. doi: 10.1093/eurheartj/ehab532.
4
Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease.低β脂蛋白血症和无β脂蛋白血症:肝脏疾病和心血管疾病。
Curr Opin Lipidol. 2020 Apr;31(2):49-55. doi: 10.1097/MOL.0000000000000663.
5
From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review.从亚临床动脉粥样硬化到斑块进展和急性冠脉事件:美国心脏病学会最新综述。
J Am Coll Cardiol. 2019 Sep 24;74(12):1608-1617. doi: 10.1016/j.jacc.2019.08.012.
6
Atherosclerosis.动脉粥样硬化。
Nat Rev Dis Primers. 2019 Aug 16;5(1):56. doi: 10.1038/s41572-019-0106-z.
7
Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors.正常 LDL 胆固醇水平与无风险因素的亚临床动脉粥样硬化有关。
J Am Coll Cardiol. 2017 Dec 19;70(24):2979-2991. doi: 10.1016/j.jacc.2017.10.024.
8
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病。1. 来自遗传、流行病学和临床研究的证据。欧洲动脉粥样硬化学会共识小组的共识声明。
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
9
Can LDL cholesterol be too low? Possible risks of extremely low levels.LDL 胆固醇会不会过低?极低水平可能带来的风险。
J Intern Med. 2017 Jun;281(6):534-553. doi: 10.1111/joim.12614.
10
Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.从生命早期开始长期暴露于较低的低密度脂蛋白胆固醇水平对冠心病风险的影响:一项孟德尔随机分析。
J Am Coll Cardiol. 2012 Dec 25;60(25):2631-9. doi: 10.1016/j.jacc.2012.09.017. Epub 2012 Oct 17.